OTC Pre-Market Testing Could Lead To Safer Widespread Usage – Ganley
This article was originally published in The Tan Sheet
Executive Summary
Distribution of an OTC drug within a limited geographic region "during the approval process" could help identify and eliminate possible safety issues before widespread national availability, Center for Drug Evaluation & Research Division of OTC Drug Products Director Charles Ganley, MD, asserted